<DOC>
	<DOCNO>NCT02448576</DOCNO>
	<brief_summary>The purpose study compare whether prophylactic cranial irradiation patient advanced triple negative breast cancer response first line chemotherapy could prolong brain-metastasis free survival .</brief_summary>
	<brief_title>PCI Advanced Triple Negative Breast Cancer Patients Who Response 1st Line Chemotherapy</brief_title>
	<detailed_description>This phase III , randomize , control , open , multicenter clinical trial , design ass efficacy safety prophylactic cranial irradiation ( PCI ) advance triple negative breast cancer response first line chemotherapy . Compare PCI group observation group evaluate brain metastasis-free survival , cumulative risk brain metastasis within 1 year , progression-free survival , overall survival , quality life measure The Europe organization research treatment cancer , Quality life Questionnaire-cancer 30 ( EORTC-QLQ-C30 ) questionnaire score function central nervous measure The Europe organization research treatment cancer , Quality life Questionnaire-brain cancer 20 ( EORTC-QLQ-BN20 ) questionnaire score woman advance triple negative breast cancer response first line chemotherapy .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Triple Negative Breast Neoplasms</mesh_term>
	<criteria>1 . Signed informed consent ; 2 . Age 18 65 year ; 3 . Documented advanced breast cancer , clinical pathological confirm ; 4 . Immunohistochemical examination : ER &lt; 1 % + , progestin receptor ( PR ) &lt; 1 % + , HER2 /+ HER2 ( ++ ) negative result FISH ; 5 . A response four eight cycle first line chemotherapy ; 6 . Life expectancy longer six month evaluate investigator ; 7 . A performance status 0 2 , accord criterion World Health Organization ( high score indicate poor performance status ) 8 . Less grade 1 ( Common Terminology Criteria grade version 4.0 ) treatmentrelated toxicity ; 9 . Adequate baseline organ function . 1 . History another malignancy . 2 . Pregnancy gestation 3 . Definite diagnosed central nervous system ( CNS ) leptomeningeal metastases 4 . Serious cardiac illness medical condition 5 . Known history related central nervous system leptomeningeal disease 6 . Cognition impairment suffer mental illness 7 . Demand longterm oral administration psychotropic drug 8 . Have concurrent disease condition may interfere study participation , serious medical disorder would interfere subject 's safety ( example , active uncontrolled infection , currently active/requiring antiviral therapy hepatic biliary disease )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>phase 3 randomize control trial</keyword>
	<keyword>prophylactic cranial irradiation</keyword>
	<keyword>triple negative breast cancer</keyword>
	<keyword>brain metastasis</keyword>
	<keyword>advanced breast cancer</keyword>
</DOC>